News & Views
BMS closures hit 160 in Ireland
Mar 21 2014
Bristol-Myers Squibb (BMS) has announced plans to shut one of its bulk pharmaceutical manufacturing plants in Ireland by the end of 2015, which will see the loss of 130 jobs at the Cruiserath, Dublin site. A further 30 jobs will be lost at the company’s Swords plant, also in County Dublin, due to the shutdown of a single operating unit. This site, which currently employs around 320 people, will continue with bulk pharmaceuticals production. A spokesperson for BMS said that the decision was made on the back of changes in demand for the products currently manufactured at the Cruiserath site.
BMS’ general manager of API operations-Ireland Susan Hynes said : “Bristol-Myers Squibb has a long history in Ireland and the company’s presence here plays an important role in the BMS global manufacturing network. The company is working with IDA Ireland to explore potential future uses of the Cruiserath facility and will endeavour to minimise job losses in Ireland”.
Opened for production in 2004, the BSM Cruiserath plant began is a multifunctional, automated bulk production pharmaceutical plant producing medicines for hypertension diabetes and HIV.
Digital Edition
International Labmate Buyers' Guide 2024/25
June 2024
Buyers' Guide featuring: Product Listings & Manufacturers Directory Chromatography Articles - Enhancing HPLC Field Service with fast-response, non-invasive flowmeters - Digital transformatio...
View all digital editions
Events
Jul 20 2024 Denver, CO, USA
Jul 21 2024 Cape Town, South Africa
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China